Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany

The aim of this health economic analysis was to compare the cost-effectiveness of ticagrelor versus clopidogrel within the German health care system. A two-part decision model was adapted to compare treatment with ticagrelor or clopidogrel in a low-dose acetylsalicylic acid (ASA) cohort (≤150 mg) fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Theidel, Ulrike, Asseburg, Christian, Giannitsis, Evangelos, Katus, Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2013
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269206/
https://www.ncbi.nlm.nih.gov/pubmed/23474908
http://dx.doi.org/10.1007/s00392-013-0552-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269206/
https://www.ncbi.nlm.nih.gov/pubmed/23474908
http://dx.doi.org/10.1007/s00392-013-0552-7

Ejemplares similares